PELEUS
Achilles Therapeutics Limited
Mark For: PELEUS® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87850414 |
| Registration Number | 5743057 |
| Mark Literal Elements | PELEUS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2019-05-07 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Mark Harrison |
| Attorney Name | Mark Harrison |
| Attorney Docket Number | 60895-428798 |
| Law Office Assigned | N30 |
| Employee Name | PAINTER, VALERIYA SHER |
Timeline
| 2018-03-26 | Application Filed |
| 2019-01-01 | Location: TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED |
| 2019-01-01 | Status: Live/Pending |
| 2019-01-01 | Transaction Date |
| 2019-02-19 | Published |
| 2019-02-19 | Published for Opposition |
| 2019-05-07 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-05-07 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2019-05-07 | Trademark Registered |
| 2024-05-07 | Maintenance Early File Date |
| 2025-05-07 | Maintenance On Time Date |
| 2025-11-07 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Achilles Therapeutics Limited |
| Address | Gunnels Wood Road Stevenage Bioscience Catalyst Stevenage ENGLAND SG12FX |
| Legal Entity Type | Limited Company Of England & Wales |
| Legal Entity State | ENGLAND |
Documents
 Drawing | JPEG | 2018-03-26 |
 TEAS RF New Application | MULTI | 2018-03-26 |
| Teas Change of Owner Address | XML | 2018-05-08 |
| Notation to File | XML | 2018-07-11 |
| Offc Action Outgoing | MULTI | 2018-07-11 |
| XSearch Search Summary | XML | 2018-07-11 |
| Response to Office Action | MULTI | 2018-12-24 |
| Amendment and Mail Process Complete | MULTI | 2018-12-25 |
| Examiners Amendment | XML | 2018-12-28 |
| Notation to File | XML | 2018-12-28 |
| Amendment and Mail Process Complete | MULTI | 2018-12-29 |
| Amendment to Delete or Correct Basis | MULTI | 2019-01-02 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-01-02 |
| Notice of Publication | XML | 2019-01-30 |
| Notification Of Notice of Publication | XML | 2019-01-30 |
| OG Publication Confirmation | XML | 2019-02-19 |
| Registration Certificate | 2019-05-07 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Medical and veterinary preparations for therapeutic purposes namely, pharmaceutical and veterinary preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; pharmaceutical products for the diagnosis, prevention and treatment of cancer; pharmaceutical preparations for cancer therapy; antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; vaccines; pharmaceutical preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
IC 009. US 021 023 026 036 038. G & S: Bioinformatics software for sequence data analysis; computer software platforms for sequence data analysis in the fields of cancer evolution and new cancer therapies, immune response disorders, genetic conditions, infectious diseases and vascular disease
IC 040. US 100 103 106. G & S: Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies
IC 042. US 100 101. G & S: Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies; and research and design relating thereto; industrial analysis and research services in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services involving the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; providing software as a service for the identification of clonal neo-antigens; providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; providing a bioinformatics platform featuring computer software for identifying clonal neoantigens
IC 044. US 100 101. G & S: Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies |
| GS0051 | Medical and veterinary preparations for therapeutic purposes namely, pharmaceutical and veterinary preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; pharmaceutical products for the diagnosis, prevention and treatment of cancer; pharmaceutical preparations for cancer therapy; antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; vaccines; pharmaceutical preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2019-05-07 | |
| PUBLISHED FOR OPPOSITION | 2019-02-19 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-19 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-30 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-01-01 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-12-28 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2018-12-28 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2018-12-28 | 92836 |
| EXAMINER'S AMENDMENT ENTERED | 2018-12-28 | 88888 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-12-24 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-12-24 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-12-24 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-07-11 | 6325 |
| NON-FINAL ACTION WRITTEN | 2018-07-11 | 92836 |
| NON-FINAL ACTION E-MAILED | 2018-07-11 | 6325 |
| ASSIGNED TO EXAMINER | 2018-07-10 | 92836 |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2018-05-08 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2018-05-08 | 88888 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-04-03 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-03-29 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 